Humacyte
CompanyUnited StatesFounded 2004
Humacyte develops 2 assets, the furthest in phase 3 (Acellular Tissue Engineered Vessel in end-stage renal disease). Mostly other; based in the United States, founded in 2004.
- 2
- Assets
- Furthest stage
- Phase 3
- 3
- Trials
- 3
- Signals
Pipeline
2Acellular Tissue Engineered Vessel
Acellular tissue-engineered vascular graft for hemodialysis access.
Phase 3, Other, end-stage renal disease
Coronary Tissue Engineered Vessel
Tissue-engineered vascular graft provides a bypass route for blood flow around obstructed coronary arteries.
Phase 2, Other, coronary artery disease
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms1
- Trials3
- Signals5
- Similar companies6